Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer

IMPORTANCE: Patients with estrogen receptor (ER)–positive breast cancer have a long-term risk for fatal disease. However, the tumor biological factors that influence the long-term risk and the benefit associated with endocrine therapy are not well understood. OBJECTIVE: To compare the long-term surv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Yu, Nancy Y., Iftimi, Adina, Yau, Christina, Tobin, Nicholas P., van ’t Veer, Laura, Hoadley, Katherine A., Benz, Christopher C., Nordenskjöld, Bo, Fornander, Tommy, Stål, Olle, Czene, Kamila, Esserman, Laura J., Lindström, Linda S.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6692699/
https://ncbi.nlm.nih.gov/pubmed/31393518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.1856
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars